HCSGD entry for TBX1
1. General information
Official gene symbol | TBX1 |
---|---|
Entrez ID | 6899 |
Gene full name | T-box 1 |
Other gene symbols | CAFS CTHM DGCR DGS DORV TBX1C TGA VCFS |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network
This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0001525 | Angiogenesis | ISS | biological_process |
GO:0001568 | Blood vessel development | ISS | biological_process |
GO:0001708 | Cell fate specification | ISS | biological_process |
GO:0001755 | Neural crest cell migration | ISS | biological_process |
GO:0001934 | Positive regulation of protein phosphorylation | ISS | biological_process |
GO:0001945 | Lymph vessel development | ISS | biological_process |
GO:0001974 | Blood vessel remodeling | IEA | biological_process |
GO:0002053 | Positive regulation of mesenchymal cell proliferation | ISS | biological_process |
GO:0003007 | Heart morphogenesis | ISS | biological_process |
GO:0003148 | Outflow tract septum morphogenesis | ISS | biological_process |
GO:0003151 | Outflow tract morphogenesis | ISS | biological_process |
GO:0003677 | DNA binding | IDA | molecular_function |
GO:0003700 | Sequence-specific DNA binding transcription factor activity | IDA | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0006351 | Transcription, DNA-templated | IEA | biological_process |
GO:0006357 | Regulation of transcription from RNA polymerase II promoter | ISS NAS | biological_process |
GO:0007368 | Determination of left/right symmetry | ISS | biological_process |
GO:0007389 | Pattern specification process | ISS | biological_process |
GO:0007498 | Mesoderm development | ISS | biological_process |
GO:0007507 | Heart development | IMP | biological_process |
GO:0007517 | Muscle organ development | ISS | biological_process |
GO:0007605 | Sensory perception of sound | ISS | biological_process |
GO:0008283 | Cell proliferation | ISS | biological_process |
GO:0008284 | Positive regulation of cell proliferation | ISS | biological_process |
GO:0009952 | Anterior/posterior pattern specification | ISS | biological_process |
GO:0021644 | Vagus nerve morphogenesis | ISS | biological_process |
GO:0030855 | Epithelial cell differentiation | ISS | biological_process |
GO:0030878 | Thyroid gland development | ISS | biological_process |
GO:0035176 | Social behavior | ISS | biological_process |
GO:0035909 | Aorta morphogenesis | ISS | biological_process |
GO:0042471 | Ear morphogenesis | ISS | biological_process |
GO:0042472 | Inner ear morphogenesis | ISS | biological_process |
GO:0042473 | Outer ear morphogenesis | ISS | biological_process |
GO:0042474 | Middle ear morphogenesis | ISS | biological_process |
GO:0042475 | Odontogenesis of dentin-containing tooth | ISS | biological_process |
GO:0042693 | Muscle cell fate commitment | ISS | biological_process |
GO:0042803 | Protein homodimerization activity | IDA | molecular_function |
GO:0043410 | Positive regulation of MAPK cascade | ISS | biological_process |
GO:0043565 | Sequence-specific DNA binding | IDA | molecular_function |
GO:0043587 | Tongue morphogenesis | ISS | biological_process |
GO:0044344 | Cellular response to fibroblast growth factor stimulus | ISS | biological_process |
GO:0045596 | Negative regulation of cell differentiation | ISS | biological_process |
GO:0045893 | Positive regulation of transcription, DNA-templated | IDA ISS | biological_process |
GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | ISS | biological_process |
GO:0046983 | Protein dimerization activity | TAS | molecular_function |
GO:0048384 | Retinoic acid receptor signaling pathway | ISS | biological_process |
GO:0048514 | Blood vessel morphogenesis | ISS | biological_process |
GO:0048538 | Thymus development | IMP | biological_process |
GO:0048644 | Muscle organ morphogenesis | ISS | biological_process |
GO:0048701 | Embryonic cranial skeleton morphogenesis | ISS | biological_process |
GO:0048703 | Embryonic viscerocranium morphogenesis | IMP | biological_process |
GO:0048752 | Semicircular canal morphogenesis | ISS | biological_process |
GO:0048844 | Artery morphogenesis | ISS | biological_process |
GO:0050679 | Positive regulation of epithelial cell proliferation | ISS | biological_process |
GO:0060017 | Parathyroid gland development | IMP | biological_process |
GO:0060023 | Soft palate development | IMP | biological_process |
GO:0060037 | Pharyngeal system development | IMP | biological_process |
GO:0060325 | Face morphogenesis | ISS | biological_process |
GO:0060415 | Muscle tissue morphogenesis | ISS | biological_process |
GO:0060982 | Coronary artery morphogenesis | ISS | biological_process |
GO:0070166 | Enamel mineralization | ISS | biological_process |
GO:0071300 | Cellular response to retinoic acid | ISS | biological_process |
GO:0071600 | Otic vesicle morphogenesis | IEA | biological_process |
GO:0072513 | Positive regulation of secondary heart field cardioblast proliferation | IEA | biological_process |
GO:0090103 | Cochlea morphogenesis | ISS | biological_process |
GO:0097152 | Mesenchymal cell apoptotic process | ISS | biological_process |
GO:2000027 | Regulation of organ morphogenesis | ISS | biological_process |
GO:2001037 | Positive regulation of tongue muscle cell differentiation | ISS | biological_process |
GO:2001054 | Negative regulation of mesenchymal cell apoptotic process | ISS | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0812722085 | 0.9523845143 | 0.6012270377 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0500930259 |
GSE13712_SHEAR | Up | 1.4370289323 |
GSE13712_STATIC | Up | 1.1517976159 |
GSE19018 | Up | 0.0982896489 |
GSE19899_A1 | Up | 0.1510093931 |
GSE19899_A2 | Up | 0.2018931024 |
PubMed_21979375_A1 | Up | 0.1405586806 |
PubMed_21979375_A2 | Up | 0.0241562754 |
GSE35957 | Down | -0.0971048184 |
GSE36640 | Up | 0.0919605481 |
GSE54402 | Up | 0.0857202622 |
GSE9593 | Up | 0.0441582498 |
GSE43922 | Up | 0.0706939381 |
GSE24585 | Down | -0.2727206916 |
GSE37065 | Up | 0.0402128101 |
GSE28863_A1 | Down | -0.0288713324 |
GSE28863_A2 | Down | -0.0041354421 |
GSE28863_A3 | Up | 0.4459500350 |
GSE28863_A4 | Up | 0.0535920102 |
GSE48662 | Up | 0.1868581822 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-1180-3p | MIMAT0005825 | MIRT035924 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-744-5p | MIMAT0004945 | MIRT037556 | CLASH | Functional MTI (Weak) | 23622248 |
hsa-miR-484 | MIMAT0002174 | MIRT041674 | CLASH | Functional MTI (Weak) | 23622248 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 8 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27081703 | The Cancer Genome Atlas network has revealed that the 'mesenchymal' epithelial ovarian cancer (EOC) subtype represents the poorest outcome, indicating a crucial role of stromal cancer-associated fibroblasts (CAFs) in disease progression |
27081703 | The cooperative role of CAFs in EOC metastasis has long been recognized, but the mechanisms of stromal CAFs activation are still obscure |
27081703 | Therefore, we carried out an integrative analysis to identify the regulator genes that are responsible for CAFs activation in microdissected tumor stroma profiles |
27081703 | Here, we determined that myristoylated alanine-rich C-kinase substrate (MARCKS) was highly expressed in ovarian stroma, and was required for the differentiation and tumor promoting function of CAFs |
27081703 | Suppression of MARCKS resulted in the loss of CAF features, and diminished role of CAFs in supporting tumor cell growth in 3D organotypic cultures and in murine xenograft model |
27074587 | RNA-Seq and gene set enrichment anylysis revealed that ovarian cancer associated fibroblasts (CAFs) are mitotically active compared with normal fibroblasts (NFs) |
27074587 | Cellular senescence is observed in CAFs treated with H2O2 as shown by elevated SA-beta-gal activity and p21 (WAF1/Cip1) protein levels |
27074587 | Blockage of autophagy can increase ROS production in CAFs, leading to cell cycle arrest in S phase, cell proliferation inhibition and enhanced sensitivity to H2O2-induced cell death |
27074587 | There was relatively high lactate content in CAFs than in NFs |
27074587 | Blockage of autophagy can sensitize CAFs to chemotherapeutic drug cisplatin, implicating that autophagy might possess clinical utility as an attractive target for ovarian cancer treatment in the future |
26629698 | OSCCs, especially those that have bypassed cellular senescence, produce an array of proteins and metabolites that induce cellular senescence in the normal surrounding cells; indeed, senescence is a common property of cancer-associated fibroblasts (CAFs) |
26629698 | Thus, not all keratinocytes in the tumour tissue may be tumourigenic and may instead act as promoters of tumour growth and progression analogous to the much-studied CAFs which co-evolve with the genetically altered tumourigenic cells |
24074947 | However, recent evidence suggests that the initiation and development of epithelial cancer results from a close interplay with its altered tissue microenvironment, with chronic inflammation, stromal senescence, autophagy, and the activation of cancer-associated fibroblasts (CAFs) playing possible primary roles |
24579734 | Throughout the review we attempt to draw many parallels to other systems including the role senescent cells play in the tumor microenvironment and their significant molecular and phenotypic similarities to cancer associated fibroblasts (CAFs) |
22500976 | BACKGROUND: Cancer-Associated Fibroblasts (CAFs) are significant components of solid malignancies and play central roles in cancer sustainability, invasion and metastasis |
22500976 | In this study we have investigated the invasive capacity and matrix remodelling properties of human lung CAFs after exposure to ablative doses of ionizing radiation (AIR), equivalent to single fractions delivered by stereotactic ablative radiotherapy (SART) for medically inoperable stage-I/II non-small-cell lung cancers |
22500976 | METHODS: CAFs were isolated from lung tumour specimens from 16 donors |
22500976 | The migrative and invasive capacities of CAFs were thereafter determined after a sub-lethal single radiation dose of 18 Gy |
22500976 | RESULTS: Exposing CAFs to 1 x 18 Gy resulted in a potent induction of multiple nuclear DDR foci (> 9/cell) with little resolution after 120 h, induced premature cellular senescence and inhibition of the proliferative, migrative and invasive capacity |
22500976 | CONCLUSIONS: Our data indicate that ablative doses of radiation exert advantageous inhibitory effects on the proliferative, migratory and invasive capacity of lung CAFs |
22500976 | The reduced motility of irradiated CAFs might be a consequence of stabilized focal contacts via integrins |
18842679 | Fibroblasts located adjacent to the tumor [cancer-associated fibroblasts (CAFs)] that constitute a large proportion of the cancer-associated stroma facilitate the transformation process |
18842679 | In this study, we compared the biological behavior of CAFs that were isolated from a prostate tumor to their normal-associated fibroblast (NAF) counterparts |
18842679 | CAFs formed more colonies when seeded at low cell density, exhibited a higher proliferation rate and were less prone to contact inhibition |
18842679 | In contrast to the general notion that high levels of alpha-smooth muscle actin serve as a marker for CAFs, we found that prostate CAFs express it at a lower level compared with prostate NAFs |
18842679 | Microarray analysis revealed a set of 161 genes that were altered in CAFs compared with NAFs |
18842679 | We focused on whey acidic protein four-disulfide core domain 1 (WFDC1), a known secreted protease inhibitor, and found it to be downregulated in the CAFs |
10708479 | Isolation of the genomic sequence revealed that the gene covered a segment of 6 kb and spanned 11 exons from the translation initiation site ATG to the termination signal TGA |
Entries Per Page
Displaying Page of